文献速递技术与安全头颈US

包膜下注射超声造影剂鉴别静脉超声造影呈均匀增强的良恶性淋巴结病变

Subcapsular Injection of Ultrasonic Contrast Agent Distinguishes between Benign and Malignant Lymph Node Lesions Exhibiting Homogeneous Enhancement in Intravenous Contrast-Enhanced Ultrasound Images.
PubMed 文献 · Ultrasound Med Biol · 2020-01-06

研究纳入2012年11月至2015年7月32例静脉超声造影后呈均匀增强的浅表淋巴结病变患者,行包膜下注射超声造影剂并记录灌注特征,以粗针活检病理为金标准。病理证实良性23例、恶性9例,包膜下超声造影诊断良性24例、恶性8例,敏感度77.8%、特异度95.6%、准确度90.6%。作者认为包膜下超声造影可能有助于鉴别此类病变,淋巴管扭曲但无中断可能特异提示淋巴瘤。

要点

  • 静脉超声造影呈均匀增强的淋巴结,包膜下造影可显示淋巴管走行及灌注模式差异。
  • 淋巴瘤多表现为不均匀灌注伴淋巴管扭曲但无中断(7例中6例,85.7%)。
  • 反应性增生表现为自包膜下向中心的弥漫均匀或刷状灌注,无淋巴管扭曲。

核心结论

  • 对于静脉超声造影呈均匀增强的淋巴结,包膜下超声造影可能有助于鉴别良恶性病变。
  • 淋巴管扭曲但无中断可能特异提示淋巴瘤。

研究设计与样本

  • 研究纳入2012年11月至2015年7月32例静脉超声造影后呈均匀增强的浅表淋巴结病变患者。
  • 以粗针活检病理为金标准,计算包膜下超声造影鉴别良恶性淋巴结病变的敏感度、特异度、准确度及预测值。

关键影像表现/征象

  • 淋巴瘤多表现为不均匀灌注伴淋巴管扭曲但无中断(7例中6例,85.7%)。
  • 反应性增生淋巴结表现为自包膜下区域向中心的弥漫均匀或刷状灌注,无淋巴管扭曲。
  • 转移性淋巴结表现为淋巴管中断。

诊断标准与关键数值

  • 包膜下超声造影诊断恶性淋巴结的敏感度为77.8%、特异度为95.6%、准确度为90.6%、阳性预测值为87.5%、阴性预测值为91.7%。
  • 病理金标准:良性23例(结核2例、反应性增生21例),恶性9例(淋巴瘤7例、转移2例)。

临床应用与阅片要点

  • 对静脉超声造影呈均匀增强的浅表淋巴结,可加做包膜下超声造影观察淋巴管走行及灌注模式。
  • 发现淋巴管扭曲但无中断时,可能提示淋巴瘤。
  • 发现淋巴管中断时,可能提示转移性淋巴结。
  • 自包膜下向中心的弥漫均匀或刷状灌注且无淋巴管扭曲,可能提示反应性增生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

We aimed to evaluate whether subcapsular injection of ultrasonic contrast agent (UCA) can distinguish between benign and malignant lymph node (LN) lesions exhibiting homogeneous enhancement in intravenous contrast-enhanced ultrasound (CEUS) images. From November 2012 to July 2015, 32 patients with superficial lymphadenopathy exhibiting homogeneous enhancement after intravenous CEUS were enrolled. A small amount of UCA was injected into LNs using a subcapsular approach, and perfusion characteristics were recorded. Using the pathology identified via core needle biopsy as the gold standard, we calculated the sensitivity, specificity and accuracy of the technique in terms of distinguishing between benign and malignant LN lesions. Pathology revealed 23 cases of true benign and 9 cases of true malignant LN lesions; the former included 2 cases of tuberculosis and 21 cases of reactive hyperplasia, and the latter included 7 lymphomas and 2 metastases. Subcapsular CEUS diagnosed 24 benign and 8 malignant LN lesions. Most lymphomas (6 of 7, 85.7%) exhibited heterogeneous perfusion, with lymphatic tract distortion in the absence of interruption. Reactive hyperplasia LNs manifested as diffuse homogeneous or brush-like perfusion from the subcapsular region to the center, without lymphatic tract distortion. Metastatic LNs had lymphatic tract interruptions. The sensitivity, specificity, consistency and positive and negative predictive values were 77.8%, 95.6%, 90.6%, 87.5% and 91.7%, respectively. For LNs exhibiting uniform enhancement in intravenous CEUS imaging, subcapsular CEUS may help to distinguish between benign and malignant lesions. In particular, lymphatic distortion without interruption may specifically indicate a lymphoma.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Liu SR, Liu C, Jing HM, et al. Subcapsular Injection of Ultrasonic Contrast Agent Distinguishes between Benign and Malignant Lymph Node Lesions Exhibiting Homogeneous Enhancement in Intravenous Contrast-Enhanced Ultrasound Images. Ultrasound Med Biol. 2020. PMID: 31917043. doi:10.1016/j.ultrasmedbio.2019.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。